The growth rate of the market in Europe and the United States slows down the speed of industrial transformation
 
In recent years，Under the common effect of internal and external factors such as changes in the global pharmaceutical market pattern and strong development of my country's pharmaceutical domestic demand，my country's pharmaceutical import and export trade has achieved a large increase in achievement。January to October this year，The total amount of pharmaceutical imports and exports is 59.349 billion US dollars，increased by 39.66%year -on -year。Where，Exit 36.297 billion US dollars，increased 35.87%; imports were US $ 23052 billion，increase 46.08%。
 
Generally speaking，The stable development trend of the global pharmaceutical market provides a favorable market environment for my country's pharmaceutical foreign trade development，But the uncertain factors are still more，Global Economic Recovery Slows，Lower risk increase，The growth rate of medical trade fell，my country's traditional medical traditional advantages face new challenges，Export development mode faces changes，The high -end market needs to be broken，Challenge and opportunities coexist。
 
Trade balance continues to improve
 
From the data from 2008 to today,，my country's pharmaceutical export growth rate has been fully restored to the level before the financial crisis; thanks to the stake online sports bettingincrease stake sports betting appin the domestic market，my country's pharmaceutical import trade is also accelerating。January to October this year，my country's pharmaceutical export increase reached 9.6 billion US dollars，mainly from three parts，First, the global pharmaceutical industry layout accelerates transfer，Part of the special raw material drug procurement to China，The export of high -end pharmaceutical products has increased significantly。According to incomplete statistics，The export increase brought by it is about 2.5 billion US dollars，accounts for 26%of the total increase; second, the market share of traditional pharmaceutical products in my country continues to increase，Among them, developed markets such as Europe and the United States and Japan increased by 2.8 billion US dollars，Emerging market increases to $ 3.5 billion，Total 63%of the incremental increase; third, the export of some domestic diagnosis and treatment equipment to develop towards the mid -to -high -end，Effectively enter the market of developed countries such as Europe and the United States，Increase is about $ 800 million，accounting for 8%of the incremental。
 
In addition，Domestic demand remains strong growth momentum，Pharmaceutical imports increase the historical high，The surplus accounts for 22.32%，3.4 percentage points from the same period last year，Trade balance continues to improve。
 
The growth rate of the European and American markets slowed
 
Show according to GTI data，By September 2011，Global pharmaceutical trade generally increases，EU、US pharmaceutical trade amounts were US $ 135.8 billion and $ 76.7 billion，year -on -year increases were 8.02%and 1.76%, respectively，The growth rate decreased by 3.57 and 7.81 percentage points, respectively; the unit price of the overall pharmaceutical trade was declining，Among them, the average price of US pharmaceutical imports fell by 4.67%，EU decreased by 7.77%。Data display，Europe and America comes from the significant growth of medical imports in developing countries，Where，The United States、EU、Japan、Australia's imports from China are 29.06%、31.39%、26.37%and 136.18%。
 
The emerging pharmaceutical market continues to maintain stake betting apprelatively rapid development，Russia、Stake Sports BettingAustralia、ASEAN、The growth rate of the Ukrainian market is significantly higher than the developed market。According to GTI data，January to September，The growth rate of medical imports of the above market reached 13.45%, respectively、20.2%、19.61%、21.32%，African market growth is about 10%。
 
Since the second half of the year，Some companies in my country have increased their development in emerging markets，Chinese pharmaceutical products continue to increase in emerging market share。Where，APIP、Medical equipment, especially diagnosis and treatment equipment products, the most significant growth rate。Customs data display，From January to October, the growth rate of products and diagnosis and treatment equipment in my country reached 38.14%, respectively、69.97%，Small raw medicines generally account for 30%to 40%share in emerging markets，Diagnosis and treatment equipment products in Russia、Brazil、ASEAN and other market share has increased significantly for three consecutive years，The share reached 11.75%、8.32%and 8.69%，The growth of emerging market growth in the next two years is still optimistic。
 
Industrial transformation speed accelerates
 
In recent years，The international pharmaceutical industry moves to Asia，directly drive the export of my country's characteristic raw materials and western medicine preparations to increase significantly。January to October this year，Western medicine preparation exports 1.715 billion US dollars，increased by 37.95%year -on -year，higher than the average growth rate of exports of medical insurance products，Especially for the EU、Australian market increased significantly，The increase reached 69.44%, respectively、1166.58%。At the same time，Domestic pharmaceutical companies have accelerated from the transition from raw materials to characteristic raw materials and preparations，Some companies，Especially Zhejiang、Jiangsu Pharmaceutical Enterprise Features、The export scale of the preparation continues to expand。
 
January to October，my country's medical device exports 12.657 billion US dollars，year -on -year increase of 54.17%，The proportion increases 4 percentage points，to 34.87%。From the perspective of product stake sports betting appstructure，stake online sports bettingConventional medical device products continue to maintain a competitive advantage of quality and low price，Medical dressing、Disposable consumables、Healthcare Kang Repeated Supplies、Exit of oral equipment and materials increased by 106.75%, respectively、49.16%、41.34%、58.37%。Europe、Mei、Day and other developed market status is firm，The increase is 56.98%、47.02%、41.75%，Market share continues to increase。At the same time，X -ray machine、CT、MRI、Ultrasound、High -end diagnosis and treatment equipment represented by nuclear imaging equipment increases significantly，Where，MRI's resonance imaging device export value increased by 23.97%year -on -year，X -ray fault inspector、Color ultrasonic diagnostic export volume increased by more than 20%，It is worth noting is，The export of high -end diagnosis and treatment equipment is still dominated by "three capital" enterprises，accounting for 81.32%。
 
The export of the raw and drug continues to rise
 
The export of the raw and drug to get rid of the influence of the financial crisis，Export volume further increases，increase to 29.28%，Export value 18.198 billion US dollars，Growing 28.19%，But the average price is still hovering at the bottom，decreased by 0.84%year -on -year。Among them, the export volume to India increased by 32.42%; at the same time，my country's raw materials continue to squeeze the basic saturated EU、North American Market，Traditional major raw materials and competitive characteristics of the characteristic raw material market share continued to increase; in addition，ASEAN、Brazil、Eastern European pharmaceutical industry starts development，The demand for the raw and drug continues to expand，The above factors are good for the export volume of the raw materials in my country continues to rise。
 
January to October，The export of Chinese medicine products in my country increased significantly by 42.27%，Extract、Export of Chinese medicinal materials increased by 49.2%year -on -year、28.25%，The weight of the Asian market continues to expand，57.66%of the proportion of exports of Chinese medicine categories。But affected by the "EU Traditional Herbal Pharmaceutical Instructions"，This year'My stake betting apps stake betting appChinese medicine exports exported to the European Union has an obvious front high and low trend，Exit peak appeared in March，increased as much as 506.37%，The following months fell to 70 % of the same period last year。
 
Due to the slow recovery of the global economy，European and American pharmaceutical market growth is limited，The emerging pharmaceutical market continues to grow significantly. There is a certain uncertainty，The continuous growth of the demand for the international pharmaceutical market is not optimistic，Increasing the risk of medical exports in my country。But at the same time，European and American and Japanese markets still have potential to dig，my country's high -end pharmaceutical products exports have initially achieved results; the market diversification strategic space is huge，The advantages of my country's pharmaceutical products will be further reflected，It is conducive to the further expanding market share of enterprises。Comprehensive consideration of various factors，2012 Chinese pharmaceutical foreign trade will continue to maintain a growth trend，But the growth rate will fall。(Liu Weihong)